Orthopedic extremities specialist Wright Medical Group (WMGI)
is going through one of those stretches where everything looks like a
mess. The company is still navigating through the Augment FDA rejection,
while also selling its major joint reconstruction business and trying
to improve the sales and efficiency of the extremities operation.
For
all of the noise, though, this is a company with growing share in a
fast-growing niche of the orthopedics market and one with ongoing
improvements in profitability as well. These shares may not pop out
immediately as being particularly undervalued, but between the growth,
profit improvement, and M&A possibilities, I continue to believe
that Wright Medical shares can head higher from here.
Continue reading here:
Amidst A Mess, Wright Medical's Extremity Business Is Strong
No comments:
Post a Comment